 |
인쇄하기
취소
|
KFDA approves first embryonic stem cell study
A clinical study using embryonic stem cells was approved for the first time in Korea on Wednesday.
The Korea Food and Drug Administration said it has approved CHA Bio & Diostech’s request to conduct a clinical study using embryonic stem cell in treating macular degeneration which can lead to sight loss.
The clinical trial will be conducted to prove the stem cells’ effect on Stargardt’s m...
The Korea Food and Drug Administration said it has approved CHA Bio & Diostech’s request to conduct a clinical study using embryonic stem cell in treating macular degeneration which can lead to sight loss.
The clinical trial will be conducted to prove the stem cells’ effect on Stargardt’s m...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.